The Efficacy and Tolerability of Duloxetine for the Treatment of Panic Disorder

NCT00438971 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Panic Disorder

Interventions

DRUG: Duloxetine

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]